Insider Trading & Ownership - SAB Biotherapeutics Inc. (SABS)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SAB Biotherapeutics Inc.
Goto Prev, 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-10-13
Purchase
2021-10-15
10:51 am
Big Cypress Acquisition Corp. BCYP Katz Ilan
Director
10% Owner
500 $10.11 $5,053 3,049,325
(Indirect
Direct)
View
2021-10-14
Purchase
2021-10-15
10:48 am
Big Cypress Acquisition Corp. BCYP Reich Samuel J
CEO and CFO
10% Owner
1,000 $10.11 $10,110 3,048,825
(Indirect
Direct)
View
2021-10-01
Purchase
2021-10-05
5:00 pm
Big Cypress Acquisition Corp. BCYP Spragens Jeffrey G
Director
13,000 $10.07 $130,910 13,000
(Direct)
View
2021-10-01
Purchase
2021-10-05
5:00 pm
Big Cypress Acquisition Corp. BCYP Katz Ilan
Director
10% Owner
1,000 $10.09 $10,090 3,048,825
(Indirect
Direct)
View
2021-01-14
Purchase
2021-01-14
1:33 pm
Big Cypress Acquisition Corp. BCYP Reich Samuel J
CEO and CFO
10% Owner
417,200 $10 $4,172,000 3,047,825
(Indirect)
View
2021-01-14
Purchase
2021-01-14
1:32 pm
Big Cypress Acquisition Corp. BCYP Katz Ilan
Director
10% Owner
417,200 $10 $4,172,000 3,047,825
(Indirect)
View
2021-01-14
Purchase
2021-01-14
1:30 pm
Big Cypress Acquisition Corp. BCYP Big Cypress Holdings LLC
CEO and CFO
10% Owner
417,200 $10 $4,172,000 3,047,825
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-10-22
Option Award
2021-10-26
9:52 pm
N/A
2024-08-05
SAB Biotherapeutics Inc. SABS Wu Hua
SVP Research & Product Dev.
116,524 $0 116,524
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:52 pm
N/A
2031-01-01
SAB Biotherapeutics Inc. SABS Polvino William James
Director
151,333 $0 151,333
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Finnegan Frederick
Chief Business Officer
263,232 $0 263,232
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
14,937,369 $0 9,967,964
(Direct)
View
2021-10-12
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
25,000 $10.08 9,967,964
(Indirect)
View
2021-10-01
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
28,587 $10.1 9,967,964
(Direct)
View
2021-10-12
Option Award
2021-10-26
9:51 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Hamilton Edward D.
10% Owner
25,000 $10.09 9,967,964
(Indirect)
View
2021-10-22
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Luke Thomas Charles
Chief Medical Officer
219,930 $0 219,930
(Direct)
View
2021-10-19
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Luke Thomas Charles
Chief Medical Officer
990 $10.1 219,930
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
Chief Executive Officer
10% Owner
8,006,048 $0 2,795,084
(Direct)
View
2021-10-07
Option Award
2021-10-26
9:50 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Sullivan Eddie Joe
Chief Executive Officer
10% Owner
2,800 $10.07 2,795,084
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:49 pm
N/A
2031-01-01
SAB Biotherapeutics Inc. SABS Turner Mervyn
Director
79,192 $0 79,192
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:49 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS Link David Charles
Director
149,483 $0 149,483
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:48 pm
N/A
2027-03-27
SAB Biotherapeutics Inc. SABS Bausch Christoph Lawrence
Chief Science Officer
375,625 $0 375,625
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:48 pm
N/A
2030-04-27
SAB Biotherapeutics Inc. SABS Ullerich Melissa Vera
Chief Communications Officer
220,817 $0 220,817
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
14,937,369 $0 9,913,018
(Direct)
View
2021-10-12
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
25,000 $10.08 9,913,018
(Indirect)
View
2021-10-01
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
28,587 $10.1 9,913,018
(Indirect)
View
2021-10-12
Option Award
2021-10-26
9:48 pm
N/A
N/A
SAB Biotherapeutics Inc. SABS HAMILTON CHRISTINE E
Director
10% Owner
25,000 $10.09 9,913,018
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:47 pm
N/A
2024-08-05
SAB Biotherapeutics Inc. SABS Pommer Jerry Lynn
Chief Compliance Officer
128,202 $0 128,202
(Direct)
View
2021-10-22
Option Award
2021-10-26
9:46 pm
N/A
2024-11-05
SAB Biotherapeutics Inc. SABS Randall Charles Hiram
Chief Strategy Officer
506,276 $0 506,276
(Direct)
View

Ownership
2021-10-22
9:27 pm
N/A
N/A
Big Cypress Acquisition Corp. SABS Hamilton Edward D.
10% Owner
0 $0 78,587
(Direct)
View

Ownership
2021-10-22
9:25 pm
N/A
N/A
Big Cypress Acquisition Corp. SABS HAMILTON CHRISTINE E
Director
10% Owner
0 $0 78,587
(Direct)
View

Ownership
2021-10-22
9:24 pm
N/A
N/A
Big Cypress Acquisition Corp. SABS Sullivan Eddie Joe
Chief Executive Officer
10% Owner
0 $0 2,800
(Direct)
View

Ownership
2021-10-22
9:23 pm
N/A
N/A
Big Cypress Acquisition Corp. SABS Luke Thomas Charles
Chief Medical Officer
0 $0 990
(Direct)
View

Ownership
2021-10-22
9:22 pm
N/A
N/A
Big Cypress Acquisition Corp. SABS Beyer Russell P
Chief Financial Officer
0 $0 2,475
(Direct)
View

Ownership
2021-01-11
5:03 pm
N/A
N/A
Big Cypress Acquisition Corp. BCYP Big Cypress Holdings LLC
10% Owner
0 $0 2,630,625
(Direct)
View

Ownership
2021-01-11
5:00 pm
N/A
N/A
Big Cypress Acquisition Corp. BCYP Reich Samuel J
CEO and CFO
10% Owner
0 $0 2,630,625
(Indirect)
View
Goto Prev, 0, 1, 2, 3, Next